Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Healthcare >

Paradigm Medical Industries Inc. (PDMI)

Add PDMI Price Alert      Hide Sticky   Hide Intro
Moderator: Risk vs Reward
Search This Board: 
Last Post: 6/26/2017 10:40:43 AM - Followers: 306 - Board type: Free - Posts Today: 0

Paradigm Medical Industries, Inc.


Contact Info
  • 4273 South 590 West
  • Salt Lake City, UT 84123
Press Releases

Paradigm Medical Industries (PDMI)

Originally the creation of a merger between French Bar Industries and Paradigm Medical Inc. in early 1993, the company quickly became skilled in the development, manufacturing, sales, and marketing of medical devices utilizing innovative and dependable diagnostic technologies for the early detection of glaucoma and other eye disorders. 

Paradigm Medical Industries, Inc. has an exceptional history of acquiring superior medical devices and companies. In 1997 Paradigm acquired OBF Labs and the Ocular Blood Flow Analyzer (BFA). Today the BFA is the only medical device available that measures both IOP and Ocular Blood Flow, two key factors in the assessment and early treatment of glaucoma, circulatory abnormalities, and other eye maladies. In 1998 the company acquired proprietary UBM technology from Humphrey Systems. After extensive research and development Paradigm enhanced this technology to be more precise, user friendly, and detailed with its introduction of the P60 UBM, the first Windows based UBM, in early 2005. In 2000 Paradigm acquired Dicon, a manufacturer of advanced diagnostic instrumentation, and expanded its product line to include perimetry, topography, and pachymetry. Only Paradigm’s sophisticated perimeters perform testing strategies with voice recognition software, now available in 26 languages. Paradigm remains dedicated to developing or acquiring new technologies and devices that preserve the vision of tomorrow, today. 

Paradigm’s expertise lies with medical devices using UBM, A-scan, B-scan, pachymetry, perimetry, ocular electrophysiology, topography, tomography, and tonometry technologies. With over 17 years of experience Paradigm specializes in providing reliable, easy-to use equipment that provide the experienced practitioner unequalled value and performance, while remaining affordable for physicians starting new practices or opening up additional satellite offices. 

Paradigm Medical Industries, Inc. is a publicly owned company traded on the OTC/PK under the symbol

Two Consultants for PDMI
Steven Bayern & Thomas F. Motter 

Steven Bayern BIO 
Listed as Consultant in PR 


Mr. Bayern has over 30 years of experience in investment banking, venture capital, and trading 
and brokerage management, including having founded and served as a principal in three separate brokerage firms on Wall Street. He was founder and principal of Racz & Company, a NYSE member firm, founder and Chairman of S.J. Bayern & Company, an NASD member firm, and founder and Chairman of Win Capital Corporation, also an NASD member firm. Mr. Bayern was also involved in successfully raising capital for Paradigm Medical in 2001 and 2003, and in arranging for the merger between the Company and Vismed, Inc., dba Dicon in 2000. 

Holding an MBA from the Baruch School of Business CCNY earned in 1974, in Finance and Investments, Mr. Bayern has built his career in the financial industry based upon his ability to locate, structure and fund small cap and mid-market deals. To that end, he has consummated myriad transactions throughout his career while compiling a long and distinguished track record of success. 

In his capacity as a principal in broker/dealer ventures, Mr. Bayern has assisted a great many small and mid-size companies achieve public listing and trading status and is intimately familiar with the public equity markets on both the buy and sell sides. 

Having worked with numerous companies throughout the course of his career and having raised many hundreds of millions of dollars in equity capital for them, Mr. Bayern brings an invaluable skill-set and wealth of experience to any company in search of capital. His ability to locate, structure and shepherd transactions throughout the process is critical and his connections at virtually every level of Wall Street is of vital importance to any company seeking seed, bridge, mezzanine or ongoing capital up to and beyond the domestic sources serve to compliment the success of any client’s funding endeavors. 

Racz & Company Mentioned here in NY Times Article 1981 

Thomas F. Motter is no scrub promoter IMO... Check out his BIO 

Mr. Motter has worked in the eye care industry for over 30 years, including management 
positions at SmithKline Beckman's eye division over a 15 year period. Mr. Motter founded Paradigm 
Medical and served as Chairman of the Board and Chief Executive Officer of the Company from 1993 
to 2002. As founder of Paradigm Medical, Mr. Motter pioneered the use of Nd-yag laser for cataract 
removal and was at the forefront in the introduction of new surgical procedures utilizing ultrasound and 
laser technologies in all facets of soft tissue management.

SmithKline Beckman was merged with what ultimately became GSK one of the largest pharma companies behind Pfizer 

The Beecham Group plc was a British pharmaceutical company. It was once a constituent of the FTSE 100 Index. Beecham, after having merged with SmithKline Beckman, merged with Glaxo Wellcome to become GlaxoSmithKline (GSK). GSK still uses the Beechams brand name in the UK for its over-the-counter cold and flu relief products.


Randall A. Mackey

Chairman of the Board of Directors, PDMI

Attorney and Counselor at Law at Mackey Price & Mecham



After receiving his two law degrees, Mr. Mackey joined the law firm of Hogan & Hartson in Washington, D.C. where he practiced extensively in the areas of corporate and securities law and administrative law. In 1979, he returned to Utah and joined the Salt Lake City law firm of Fabian & Clendenin. He was a shareholder, Vice President, and a director of that firm prior to joining the predecessor of Mackey Price & Mecham in 1989. While at Fabian & Clendenin, Mr. Mackey’s principal areas of practice included corporate and securities law and banking law. Mr. Mackey also served from 1981 to 1988 as an Adjunct Professor at the University of Utah, teaching courses in Constitutional Law and International Law.

Mr. Mackey has been active in community affairs. He has previously served as Chairman of the Board of Trustees of Salt Lake Community College, a member of the Utah State Board of Education, a director of the Harvard Alumni Association in Cambridge, Massachusetts, a Vice President of the Columbia Law School Association in New York City, and a director of the Salt Lake Education Foundation. Mr. Mackey has also served as a trustee of Ballet West, the Utah Opera Company, and the Gina Bachauer International Piano Foundation and a director of the Utah Arts Counsel.

Mr. Mackey additionally served on the Utah National Steering Committee in 1992 and 1988 of President George Bush’s Campaign Committee, as Chairman of the Higher Education Committee for Governor Jon Huntsman’s Campaign Committee in 2004, a member of Governor Huntsman’s Transition Committee from 2004 to 2005, a member of the Steering Committee of Governor Michael Leavitt’s Campaign Committee in 1992, and a member of the Executive Committee of Governor Leavitt’s Transition Committee from 1992 to 1993.

Mr. Mackey is a member of the Utah State Bar and the District of Columbia Bar and served on the Utah State Bar Securities Advisory Committee.


Extensive experience in corporate and securities matters, including mergers and acquisitions, public offerings and private placements of equity and debt securities, business planning, business sales and divestitures, securities law compliance, shareholder matters, proxy contests, tender offers, joint ventures, limited liability company law, commercial law and insurance law. Has also had significant experience in banking work.


Mackey Price & Mecham is a business law firm based in Salt Lake City, Utah. The firm’s areas of practice include general corporate, corporate finance and securities, litigation and alternative dispute resolution, real estate, banking, estate planning, and aviation law. Mackey Price & Mecham was founded to service the needs of business organizations and enjoys a broad-based business practice.

The firm has two principal objectives: first, to provide mature businesses with the entire spectrum of corporate legal and dispute resolution services at a high level of expertise, and second, to provide emerging businesses with assistance in corporate organization, finance and capital formation, and dispute resolution (as well as assisting with the many other legal and business issues facing emerging businesses). In the past, many top Utah businesses have hired out-of-state legal counsel for representation in complex corporate and securities transactions. Mackey Price & Mecham provides the same quality of legal services on a local basis that are usually found among large out-of-state law firms.

The firm’s attorneys believe that the Rocky Mountain region is an attractive growth area for businesses. Growing businesses need quality representation from experienced legal counsel. Such counsel can facilitate a client’s growth by advising the client on how to locate sources of, and secure capital, assemble a team of professionals and management personnel, and resolve problems and disputes that might inhibit future growth and development. The attorneys at Mackey Price & Mecham are confident that their experience enables them to act as catalysts to the entrepreneurial spirit that prevails in the Rocky Mountain region.

Attorney and Counselor at Law

Fabian & Clendenin

Principal areas of practice included corporate and securities law and banking law.

Attorney and Counselor at Law

Hogan & Hartson

Practiced extensively in the areas of corporate and securities law and administrative law.

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#23417   25.8 mil left at trip 1 Risk vs Reward 06/26/17 10:40:43 AM
#23416   26.3 mil @ .0001 Risk vs Reward 06/22/17 11:58:27 AM
#23415   26.4 mil @ .0001 left Risk vs Reward 06/21/17 09:55:45 AM
#23414   26.9 mil left @ 1 folks Risk vs Reward 06/19/17 11:58:18 AM
#23413   I can't buy'em all folks lol... Eat up Risk vs Reward 06/16/17 02:54:29 PM
#23412   33% of the ask was eaten today, hoping Risk vs Reward 06/14/17 08:26:05 PM
#23411   33 percent of the ask was eaten today. Risk vs Reward 06/14/17 08:25:02 PM
#23410   Got em' all still. WillieWonka 06/14/17 08:24:18 PM
#23409   That makes sense, should've known No problem Risk vs Reward 06/14/17 08:23:30 PM
#23408   Because the price is no different then the WillieWonka 06/14/17 08:21:46 PM
#23407   31 mil left @ trip 1! Who's hungry ? Risk vs Reward 06/14/17 12:16:19 PM
#23406   If it was .25 I'd be quitting my Risk vs Reward 06/14/17 10:14:12 AM
#23405   11 mil buy, nice start to the day Risk vs Reward 06/14/17 10:13:43 AM
#23404   Ignore pre market open, just means the active Risk vs Reward 06/14/17 10:13:23 AM
#23403   Why is it showing .25 on ask? Fishmonsters 06/14/17 07:52:23 AM
#23402   WillyWonka.... If the ask is .0001 and buys are Risk vs Reward 06/13/17 02:26:46 PM
#23401   19.8 mil @ .0001 Risk vs Reward 06/13/17 01:55:35 PM
#23400   Maybe the fifth digit trading BS is over Risk vs Reward 06/13/17 09:59:40 AM
#23399   4 th mm back/ 20 mil at 1 sheesh Risk vs Reward 06/13/17 09:52:27 AM
#23398   Only 3 active mm's oh how the ship Risk vs Reward 06/13/17 09:33:43 AM
#23397   8 mil on the 1 ask wtf we're Risk vs Reward 06/12/17 05:31:46 PM
#23396   45.3 mil ask size Risk vs Reward 06/12/17 11:37:04 AM
#23395   2 ask size shrunk nicely Risk vs Reward 06/08/17 10:28:14 AM
#23394   Bids back Risk vs Reward 06/07/17 03:14:31 PM
#23393   Champagne for everyone! No Bid how sweet it is Risk vs Reward 06/07/17 01:53:54 PM
#23392   20,000 shares to no Bid! Come on give Risk vs Reward 06/07/17 12:20:40 PM
#23391   wasn't me. Still sitting on mine kittie88 06/07/17 12:55:48 AM
#23390   ;) lmao How many you got left? Risk vs Reward 06/06/17 11:30:24 PM
#23389   I'm just trying to make hide or hair Risk vs Reward 06/06/17 09:49:10 PM
#23388   To add, stock was down 33% and 27 Risk vs Reward 06/06/17 09:47:17 PM
#23387   So much for the conversation on this board Risk vs Reward 06/06/17 09:45:40 PM
#23386   So 6 mil goes off when there was Risk vs Reward 06/06/17 05:00:40 PM
#23385   I like getting kicked in the sac, for Risk vs Reward 06/06/17 11:58:09 AM
#23384   Sorry 1.8 mil Risk vs Reward 06/06/17 11:56:33 AM
#23383   How's there still over a mil left when Risk vs Reward 06/06/17 11:55:55 AM
#23382   Somebody is taking a BIG DUMP! WillieWonka 06/06/17 11:51:20 AM
#23381   Come on! Drop them 5 mil and get Risk vs Reward 06/06/17 11:32:11 AM
#23380   That's all my life is, a giant tease Risk vs Reward 06/06/17 10:19:59 AM
#23379   Bid size shrinking every day. WillieWonka 06/06/17 10:13:05 AM
#23378   Another milly added to the ask size, now Risk vs Reward 06/01/17 01:41:36 PM
#23377   Bid size remains similar everyday but the ask Risk vs Reward 05/31/17 10:35:27 AM
#23376   264 million shares bought at the ask last Risk vs Reward 05/31/17 06:35:04 AM
#23375   Recent telephone call with him ( another PDMIer Risk vs Reward 05/30/17 04:05:07 PM
#23374   Hey Mr Mackey how about some news sure bet 05/30/17 03:38:06 PM
#23373   Enlightening to say the least Risk vs Reward 05/30/17 12:16:56 PM
#23372   I see .0002 and by end of day .0001 alert1100 05/30/17 12:15:24 PM
#23371   67 mil more at 2 and you'll get Risk vs Reward 05/30/17 11:35:50 AM
#23370   If I may ask, what do you see? Risk vs Reward 05/30/17 11:19:44 AM
#23369   I like what I see , need a alert1100 05/30/17 10:40:24 AM
#23368   Better happen it June cause we know sheet Risk vs Reward 05/26/17 12:12:34 PM